incidence of the metabolic syndrome is increasing worldwide with notable exceptions of some asian countries where seaweeds are commonly consumed13 men mean age 47499 yr and 14 women average age 456122 yr with at least one symptom of the metabolic syndrome were recruited in quito ecuador to a randomized doubleblinded placebocontrolled trialsubjects were assigned to either group 1 1 m placebo followed by 1 m 4 gd seaweed undaria pinnatifida or group 2 1 m of 4 gd seaweed followed by 1 m of 6 gd of seaweedblood pressure weight waist circumference inflammation biomarkers and lipids were measured monthlyrepeated measures analysis of variance with tukeys multiple comparison tests were used for statistical analysisin group 2 systolic blood pressure decreased 105 mmhg after a month of 6 gd seaweed 95 ci 41 168 mmhg p005 primarily in subjects with highnormal baseline blood pressurewaist circumference changed only for women participants with a 24 cm decrease in group 1 after treatment with placebo 95 ci 10 37 cm p001in group 2 women had a mean decrease of 21 cm after 4 gd 95 ci 04 37 cm p005 and a further 18 cm decrease after 1 m 6 gd seaweed 95  ci 01 34 p005no other changes were observedconsumption of 4 to 6 gd seaweed typical for most people in japan may be associated with low metabolic syndrome prevalence